Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.

Sectors
Healthcare
Life Sciences
First Invested
2020
Early
Company Status
NASDAQ: ACLX